Skip to content

Comparing Different Catheter Locking Solutions to Prevent Bloodstream Infections in Patients with Central Lines

Efficacy Of Recombinant Tissue Plasminogen Activator(Rt-PA)Tenecteplase, Sodium Bicarbonate Over Heparin As a Locking Solution In Prevention Of Central Line-Associated Bloodstream Infections (CLABSI) - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085363
Enrollment
90
Registered
2025-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N186- End stage renal disease

Interventions

Intervention1: Recombinant Tissue Plasminogen Activator(Rt-PA)Tenecteplase: GROUP B: Rt-PA :Tenecteplase 1mg/ml, volume adjusted with saline to match the lumen of HD catheter(non tunnelled, non cuffed

Sponsors

DrNavin B
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All incident patients undergoing insertion of first time non tunnelled hemodialysis catheter in the Haemodialysis Centre at Stanley medical college were screened and included

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1. Patients below 18 years 2. Recent COVID 19 infection patients on anticoagulation treatment, 3. INR more than 1.4, 4. Platelets less than 60 × 109 /l, 5. Clinical symptoms of infection, known malignancy, 6. Bleeding complication in the four weeks before catheter insertion, 7. Known allergy or intolerance to Tenecteplase or heparin , 8. Pregnancy or breastfeeding.

Design outcomes

Primary

MeasureTime frame
To study the incidence of Central Line-Associated Bloodstream Infections (CLABSI)Timepoint: Blood cultures will be taken if the patient develops fever/chills during the Hemodialysis session or any discharge from the Central line site

Secondary

MeasureTime frame
To study the incidence of catheter malfunction/obstruction.Timepoint: The blood flow achieved (and sustained) during the dialysis session was logged.

Countries

India

Contacts

Public ContactNavin B

Government Stanley Medical College

nephroeddy@gmail.com9841018717

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026